PharmaJet needle-free delivery enhances immune response and provides safety, efficacy, efficiency, and patient comfort for intradermal and intramuscular applications, outperforming traditional ...

- Case study highlights the long-term safety and tolerability of LIQ861 (YUTREPIA) in a PAH patient transitioning from parenteral treprostinil in INSPIRE study ...

Poster Presentation Highlights Presentation title: Does additional margin excision during LumiSystem (pegulicianine) fluorescence-guided lumpectomy surgery affect patient breast satisfaction?

Additionally, five poster presentations (one being a collaboration with patient organisations) will showcase nizubaglustat’s promise as an investigational therapy for NPC and GM1/GM2 gangliosidoses.

The poster presentation describes preliminary findings from the company’s Phase 1a study of HFK1 for HER2 low expression cancers. The first patient dosed suffers from lung metastasis of a rare ...